Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDAchieve Life Sciences Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 4 | -$0.30 | -$0.30 | -$0.30 |
| Q2 2026 | 4 | -$0.22 | -$0.22 | -$0.22 |
| Q3 2026 | 7 | -$0.35 | -$0.12 | -$0.23 |
| Q4 2026 | 3 | -$0.27 | -$0.27 | -$0.27 |
| Q1 2027 | 3 | -$0.24 | -$0.24 | -$0.24 |
| Q2 2027 | 2 | -$0.25 | -$0.25 | -$0.25 |
| Q3 2027 | 2 | -$0.27 | -$0.27 | -$0.27 |
| Q4 2027 | 2 | -$0.28 | -$0.28 | -$0.28 |
Achieve Life Sciences Inc. Earnings Date And Information
Achieve Life Sciences Inc. last posted its earnings results on Tuesday, May 12th, 2026. The company reported $-0.19 earnings per share for the quarter, topping analysts' consensus estimates of $-0.3 by $0.11. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Achieve Life Sciences Inc. has generated $-1 earnings per share over the last year ($-1.25 diluted earnings per share) and currently has a price-to-earnings ratio of -6.12. Achieve Life Sciences Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Achieve Life Sciences Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/12/2026 | Q1 2026 | -$0.30 | -$0.19 | 0.11 | $0 | $0 |
| 03/24/2026 | Q4 2025 | -$0.27 | -$0.28 | -0.01 | $0 | $0 |
| 11/06/2025 | Q3 2025 | -$0.24 | -$0.28 | -0.04 | $0 | $0 |
| 08/07/2025 | Q2 2025 | -$0.37 | -$0.37 | 0 | N/A | $0 |
| 05/13/2025 | Q1 2025 | -$0.37 | -$0.37 | 0 | N/A | $0 |
| 03/11/2025 | Q4 2024 | -$0.30 | -$0.36 | -0.06 | N/A | $0 |
| 11/07/2024 | Q3 2024 | -$0.26 | -$0.36 | -0.1 | N/A | $0 |
| 08/13/2024 | Q2 2024 | -$0.22 | -$0.25 | -0.03 | N/A | $0 |
| 05/09/2024 | Q1 2024 | -$0.24 | -$0.26 | -0.02 | N/A | $0 |
| 12/29/2023 | Q4 2023 | N/A | -$0.26 | N/A | N/A | $0 |
| 11/09/2023 | Q3 2023 | -$0.34 | -$0.34 | 0 | N/A | $0 |
| 08/14/2023 | Q2 2023 | -$0.41 | -$0.43 | -0.02 | N/A | $0 |
| 05/09/2023 | Q1 2023 | -$0.65 | -$0.50 | 0.15 | N/A | $0 |
| 05/16/2023 | Q4 2022 | N/A | -$0.81 | N/A | N/A | $0 |
| 11/14/2022 | Q3 2022 | -$1.10 | -$1.40 | -0.3 | N/A | $0 |
| 08/11/2022 | Q2 2022 | -$0.79 | -$1.13 | -0.34 | N/A | $0 |
| 05/12/2022 | Q1 2022 | -$0.82 | -$0.84 | -0.02 | N/A | $0 |
| 03/10/2022 | Q4 2021 | -$0.73 | -$0.76 | -0.03 | N/A | $0 |
| 11/09/2021 | Q3 2021 | -$1.09 | -$0.71 | 0.38 | N/A | $0 |
| 08/12/2021 | Q2 2021 | N/A | -$1.53 | N/A | N/A | $0 |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Achieve Life Sciences Inc. Earnings: FAQ's
In the previous quarter, Achieve Life Sciences Inc. (:ACHV) reported $-0.19 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.3 by $0.11.
The conference call for Achieve Life Sciences Inc.'s latest earnings report can be listened to online.
The conference call transcript for Achieve Life Sciences Inc.'s latest earnings report can be read online.
Achieve Life Sciences Inc. (:ACHV) has a recorded net income of $-54,648,000.Achieve Life Sciences Inc. has generated $-1.25 earnings per share over the last four quarters.
Achieve Life Sciences Inc. (:ACHV) has a price-to-earnings ratio of -6.12 and price/earnings-to-growth ratio is -0.39.